Affinity Investment Advisors’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $207K | Sell |
|
|||||
|
2023
Q3 | $299K | Hold |
|
|||||
|
2023
Q2 | $390K | Sell |
|
|||||
|
2023
Q1 | $478K | Hold |
|
|||||
|
2022
Q4 | $452K | Buy |
|
|||||
|
2022
Q3 | $618K | Hold |
|
|||||
|
2022
Q2 | $677K | Sell |
|
|||||
|
2022
Q1 | $935K | Sell |
|
|||||
|
2021
Q4 | $941K | Buy |
|
|||||
|
2021
Q3 | $871K | Hold |
|
|||||
|
2021
Q2 | $944K | Hold |
|
|||||
|
2021
Q1 | $1.09M | Sell |
|
|||||
|
2020
Q4 | $988K | Sell |
|
|||||
|
2020
Q3 | $1.02M | Sell |
|
|||||
|
2020
Q2 | $907K | Hold |
|
|||||
|
2020
Q1 | $580K | Buy |
|
|||||
|
2019
Q4 | $531K | Hold |
|
|||||
|
2019
Q3 | $446K | Hold |
|
|||||
|
2019
Q2 | $510K | Buy |
|